Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[New surgical options for large volume benign prostatic hyperplasia: Robot-assisted madigan procedure].

Created on 11 Nov 2026

Authors

Yulin Yuan, Yu Zhou, Ming Ma, Jian Song, Qiubo Xie, Zhongyang Yi, Yalong Xu, Tiejun Pan

Published in

Zhonghua nan ke xue = National journal of andrology. Volume 32. Issue 4. Pages 314-319.

Abstract

Objective This study aims to evaluate the efficacy and safety of urethra-sparing robot-assisted simple prostatectomy (us-RASP) as a treatment modality for benign prostatic hyperplasia (BPH). Methods A retrospective analysis of the clinical data from 25 BPH patients admitted to our medical center from June 2023 to June 2024 was performed. All 25 patients underwent us-RASP using the robotic-assisted platform with indocyanine green fluorescence imaging. The general data and perioperative indicators were analyzed. And follow-ups were completed at 3 months and 12 months postoperatively, including International Prostate Symptom Score (IPSS), prostate-specific antigen (PSA), quality of life score (QOL), maximum urinary flow rate (Qmax), post-void residual (PVR), International Index of Erectile Function-5 (IIEF-5), Male Sexual Health Questionnaire-Ejaculatory Dysfunction Score (MSHQ-EJD), International Consultation on Incontinence Modular Questionnaire-Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) and complications. Results In this group of 25 patients, the operation duration was 105 (88,132) minutes, the intraoperative blood loss was 50 (50,100) mL, and the indwelling catheter duration was 8 (7,10.5) days. Urinary tract repair was performed during the operation in 7 patients (28%). Three months after the operation, the IPSS (27 [25, 31] vs 6[4, 8]), PVR (148 [58.3,202] mL vs 55 [26,86] mL), Qmax (7.3 [3.6,9.8] mL/s vs 18.1 [15.3,23.2] mL/s), ICIQ-MLUTS (53 [44,58] vs 24[18,35] ), and PSA (7.02[4.70, 11.16] μg/L vs 1.44 [0.89, 2.15] μg/L) showed significant improvement compared to before the operation(P < 0.05). At 12 months after the operation, the IPSS (5 [3, 8]), PVR (19 [10.7,41.0] mL), ICIQ-MLUTS (21 [16,32] ), and PSA (2.03 [1.01,2.64] μg/L) showed statistically significant differences compared to 3 months after the operation (P<0.05). In terms of sexual function, among the 10 patients who had sexual activity during the follow-up period, only 1 case had retrograde ejaculation, and the remaining patients had normal ejaculation and erectile function. In terms of complications, none of the patients had true urinary incontinence or urethral stricture. Conclusion Robot-assisted Urethra-Sparing Prostatectomy is safe and effective for treating large volume BPH, especially for younger patients who require preservation of sexual function and have higher quality of life demands, or for patients with concomitant bladder diverticula or bladder stones.

PMID:
43012215
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement